LY2603618

Catalog No.S2626 Synonyms: IC-83

LY2603618 Chemical Structure

Molecular Weight(MW): 436.3

LY2603618 is a selective Chk1 inhibitor with potential anti-tumor activity in a cell-free assay. Phase 2.

Size Price Stock Quantity  
In DMSO USD 300 In stock
USD 170 In stock
USD 320 In stock
USD 970 In stock

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

5 Customer Reviews

  • BxPC-3 cells were treated with vehicle control, MK-1775 (MK), LY2603618 (LY) or MK-1775 plus LY2603618 for 48 h. Protein extracts were subjected to Western blotting and probed with anti-PARP, -p-CHK1, -CHK1, -p-CDC25C, -p-CDK1, -CDK1, -p-CDK2, -CDK2, -γH2AX, or -β-actin antibody.

    Cancer Lett 2014 10.1016/j.canlet.2014.10.015. LY2603618 purchased from Selleck.

    MK-1775 and LY2603618 synergize to induce apoptosis in AML cell lines and primary patient samples. U937 and CTS cells were treated for 8 h. Whole cell lysates were subjected to Western blotting and probed with anti-γH2AX, -pCHK1, -p-cdc25c, -p-CDK1, -p-CDK2, -CDK1, or -β-actin antibody. Densitometry measurements, as described in the Materials and methods section, are shown below the corresponding Western blot.

    J Hematol Oncol 2014 7, 53. LY2603618 purchased from Selleck.

  • Biomarker changes induced in response to gemcitabine plus Chk1 inhibitor treatment in HT29 colon carcinoma cells. HT29 colon cancer cells were exposed to 50 nM gemcitabine (+) for 16 hours followed by increasing concentrations of Chk1 inhibitor for a further 24 hours. Protein expression was characterized by immunoblotting.

    BMC Cancer 2014 14, 483. LY2603618 purchased from Selleck.

    C6 cell was trypsinized and plated at 30% confluence in DMEM. 16 hours later, LY2603618 was added at final concentrations of 0, 1, 5, 10 and 20uM. Another 24 hours later, cells were harvested in RIPA with protease and phosphatase inhibitor cocktail. Total protein concentration was measured by BCA method. Lysates equivalent to 20ug total protein were subject to Western Blot, using pS345-CHK1, g-H2AX and beta-actin (internal control) antibodies.

    Customer W, F. Z. LY2603618 purchased from Selleck.

  • Hela cell was trypsinized and plated at 30% confluence in DMEM. 16 hours later, LY2603618 was added at final concentrations of 0, 5, 10 and 25uM. Another 24 hours later, cells were harvested in RIPA with protease and phosphatase inhibitor cocktail. Total protein concentration was measured by BCA method. Lysates equivalent to 20ug total protein were subject to Western Blot, using total- CHK1, pS345-CHK1 and beta-actin (internal control) antibodies.

    LY2603618 purchased from Selleck.

Purity & Quality Control

Choose Selective Chk Inhibitors

Click to view more

Notes:

2. For more details, such as half maximal inhibitory concentrations (IC50s) and working concentrations of each inhibitor, please click on the link of the inhibitor of interest.
3. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation.
4. Orange "√" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

Biological Activity

Description LY2603618 is a selective Chk1 inhibitor with potential anti-tumor activity in a cell-free assay. Phase 2.
Targets
Chk1 [1]
(Cell-free assay)
In vitro

Chk1 is an ATP-dependent serine-threonine kinase and a key component in the DNA replication-monitoring checkpoint system activated by double-stranded breaks (DSBs). Chk1 contributes to all currently defined cell cycle checkpoints, including G1/S, intra-S-phase, G2/M, and the mitotic spindle checkpoint. By inhibiting the activity of chk1, LY2603618 prevents the repair of DNA caused by DNA-damaging agents, thus potentiating the antitumor efficacies of various chemotherapeutic agents. However, preclinical data involving LY2603618 has not been published until now. [1] Inhibition of Chk1 is predicted to enhance the effects of antimetabolites, such as gemcitabine. [2] LY2603618 treatment impairs DNA synthesis, increases DNA damage (via mitotic defects), induces apoptosis, and has synergistic activity with pemetrexed, especially in p53 mutant tumor cells. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
BT474 NF7kUVRMcW6jc3WgZZN{[Xl? MYWxJO69VQ>? NGHZRWVFVVOR NEGxOWZqdmirYnn0d{BRNUOKS{GgcIV3\Wy| M1fte|I{QTF5M{e4
MCF7 MWjLbY5ie2ViYYPzZZk> NYW5fI9nOSEQvF2= NXezb3RrTE2VTx?= MULpcohq[mm2czDQMWNJUzFibHX2[Yx{ Mn\wNlM6OTd|N{i=
Hela M33YWmtqdmG|ZTDhd5NigQ>? MUGzN|AxKG6P M3XSUWROW09? NV3IO|F7cW6qaXLpeJMhS2itMTDhZ5Rqfmm2eR?= MmfNNlQyOTRzMkS=
Calu6 MVjLbY5ie2ViYYPzZZk> M3fCTFM{ODBibl2= MXTEUXNQ NW\wXo5CcW6qaXLpeJMhS2itMTDhZ5Rqfmm2eR?= M2HwNlI1OTF2MUK0
A549 MVXGeY5kfGmxbjDhd5NigQ>? NFz0UYp,OTBizszN MXHEUXNQ M2HrcIlv\HWlZYOgZ4VtdCCleXPs[UBienKnc4S= NXTUb41lOjR7MkiyNFU>
H1299 MYHGeY5kfGmxbjDhd5NigQ>? M2\MXJ4yOCEQvF2= NEj0XmxFVVOR NGrPT|NqdmS3Y3XzJINmdGxiY4njcIUh[XK{ZYP0 M{fCSVI1QTJ6MkC1
A549 M2fa[2Z2dmO2aX;uJIF{e2G7 NGDveWh,OjBizszN MYDEUXNQ M1TUS4FkfGm4YYTld{BFVkFiZHHtZYdmKHOnboPvdkBscW6jc3Xz MXOyOFkzQDJyNR?=
H1299 NEXrbopHfW6ldHnvckBie3OjeR?= MYP+NlAh|ryP Mn\aSG1UVw>? MnK5ZYN1cX[jdHXzJGRPSSCmYX3h[4Uhe2Wwc3;yJItqdmG|ZYO= M1vDb|I1QTJ6MkC1
A549 MkjVRZBweHSxc3nzJIF{e2G7 M{S0VJ4zOCEQvF2= M1\xc2ROW09? NEC0c4JqdmS3Y3XzJIFxd3C2b4Ppdy=> M{DIO|I1QTJ6MkC1
H1299 NYOwenRCSXCxcITvd4l{KGG|c3H5 MlK0glIxKM7:TR?= M3rIcWROW09? NETBUHVqdmS3Y3XzJIFxd3C2b4Ppdy=> M2LZNlI1QTJ6MkC1
A549 NFzlSotEgXSxeHnjbZR6KGG|c3H5 M1zXU54zOCEQvF2= MmT0SG1UVw>? NHLhOWFqdmS3Y3XzJIF2fG:yaHHnfS=> NEO2No8zPDl{OEKwOS=>
H1299 NF33e3pEgXSxeHnjbZR6KGG|c3H5 NXLrR3RWhjJyIN88US=> MlTvSG1UVw>? M1ryZolv\HWlZYOgZZV1d3CqYXf5 M4XkNVI1QTJ6MkC1
A549 MkHUSpVv[3Srb36gZZN{[Xl? M{fTTJ4zOCEQvF2= NVi1OZJ5TE2VTx?= Mlm5bY5kemWjc3XzJGpPUyCjbnSgdFM5KE2DUFugdIhwe3Cqb4L5cIF1cW:w M3v2e|I1QTJ6MkC1
H1299 MojmSpVv[3Srb36gZZN{[Xl? NFnqOI1,OjBizszN MULEUXNQ NYf4[nJFcW6lcnXhd4V{KEqQSzDhcoQheDN6IF3BVGsheGixc4Doc5J6dGG2aX;u MYWyOFkzQDJyNR?=

... Click to View More Cell Line Experimental Data

In vivo In xenograft models, LY2603618 delays tumor growth when given in combination with pemetrexed. [3]

Protocol

Solubility (25°C)

In vitro DMSO 13 mg/mL (29.79 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
In vivo 2% DMSO+30% PEG400+0.5% Tween80+5% Propylene glycol 30mg/mL

* 1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 436.3
Formula

C18H22BrN5O3

CAS No. 911222-45-2
Storage powder
in solvent
Synonyms IC-83

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01358968 Completed Cancer Eli Lilly and Company June 2011 Phase 1
NCT01341457 Completed Solid Tumors Eli Lilly and Company May 2011 Phase 1
NCT01296568 Completed Advanced Cancer Eli Lilly and Company February 2011 Phase 1
NCT01139775 Completed Non Small Cell Lung Cancer Eli Lilly and Company February 2011 Phase 1|Phase 2
NCT00988858 Completed Non Small Cell Lung Cancer Eli Lilly and Company November 2009 Phase 2
NCT00839332 Completed Pancreatic Neoplasms Eli Lilly and Company March 2009 Phase 1|Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Chk Signaling Pathway Map

Chk Inhibitors with Unique Features

Related Chk Products

Tags: buy LY2603618 | LY2603618 supplier | purchase LY2603618 | LY2603618 cost | LY2603618 manufacturer | order LY2603618 | LY2603618 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID